FILE - Chairman Rep. Mike Gallagher, R-Wis., listens during a hearing of a special House committee dedicated to countering China, on Capitol Hill, Feb. 28, 2023, in Washington. Members of Congress are raising alarms about what they see as America's failure to compete with China in biotechnology, with risks to U.S. national security and commercial interests. But as the countries' rivalry expands into the biotech industry, some say that shutting out Chinese companies would onl…

February 19, 2024